EUVIMEDEUVIMED entdecken
Scoping Review

A scoping review evaluating the current state of gut microbiota and its metabolites in valvular heart disease physiopathology

Caroline Chong-Nguyen iD, Bahtiyar Yilmaz, Bernadette Coles, Harry Sokol, Andrew MacPherson, Matthias Siepe, David Reineke, Selim Mosbahi, Daijiro Tomii, Masaaki Nakase, Sarah Atighetchi, Cyril Ferro und 11 weitere

European Journal of Clinical Investigation · 2025

DOI: 10.1111/eci.14381 ↗

Kurz gefasst

Scoping Review in der Zeitschrift European Journal of Clinical Investigation, 2025. Verfasst von Caroline Chong-Nguyen und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Bern University Hospital, Inselspital, Bern, Switzerland. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Heart Valve Diseases, Aortic Valve Stenosis, Calcinosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 80 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The human microbiome is crucial in regulating intestinal and systemic functions. While its role in cardiovascular disease is better understood, the link between intestinal microbiota and valvular heart diseases (VHD) remains largely unexplored.

Methods

Peer‐reviewed studies on human, animal or cell models analysing gut microbiota profiles published up to April 2024 were included. Eligible studies used 16S rRNA or shotgun sequencing, metabolite profiling by mass spectrometry, and examined osteogenesis or fibrosis signalling in valve cells. Methods and findings were qualitatively analysed, with data charted to summarize study design, materials and outcomes.

Results

Thirteen studies were included in the review: five human, three animal and five in vitro. Of the nine studies on calcific aortic stenosis (CAS), elevated trimethylamine N‐oxide (TMAO) levels were linked to an increased risk of cardiovascular events in cohort studies, with CAS patients showing higher levels of Bacteroides plebeius , Enterobacteriaceae, Veillonella dispar and Prevotella copri . In vivo, TMAO promoted aortic valve fibrosis, while tryptophan derivatives stimulated osteogenic differentiation and interleukin‐6 secretion in valvular interstitial cells. Two studies on rheumatic mitral valve disease found altered microbiota profiles and lower short‐chain fatty acid levels, suggesting potential impacts on immune regulation. Two studies on Barlow's mitral valve disease in animal models revealed elevated TMAO levels in dogs with congestive heart failure, reduced Paraprevotellaceae , increased Actinomycetaceae and dysbiosis involving Turicibacter and E. coli .

Conclusions

TMAO has been mainly identified as a prognostic marker in VHD. Gut microbiota dysbiosis has been observed in various forms of VHD and deserve further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeHeart Valve DiseasesAortic Valve StenosisCalcinosisHumansAnimalsMethylaminesAortic ValveFibrosisRNA, Ribosomal, 16S

Stichwörter der Autor:innen

gut microbiotametabolitesosteogenesisvalvular heart disease

Substanzen

MethylaminestrimethyloxamineRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Cardiology, Bern University Hospital, Inselspital, Bern, Switzerland.
  • Department of Visceral Surgery and Medicine, Bern University Hospital, Inselspital, Bern, Switzerland.
  • Velindre University NHS Trust Library and Knowledge Service, Cardiff, UK.
  • Department of Gastroenterology, Saint Antoine Hospital, Assistance Publique-Hopitaux de Paris (APHP), Paris, France.
  • Department of Cardiac Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Faculté de médecine, Equipe neurogénétique et neurométabolomique, INSERM U930, Université François Rabelais, Tours, France.

ORCID-Profile: Caroline Chong-Nguyen, George C M Siontis

Zitieren

APA

Chong-Nguyen, C., Yilmaz, B., Coles, B., Sokol, H., MacPherson, A., Siepe, M., Reineke, D., Mosbahi, S., Tomii, D., Nakase, M., Atighetchi, S., Ferro, C., Wingert, C., Gräni, C., Pilgrim, T., Windecker, S., Blasco, H., Dupuy, C., Emond, P., …, & Siontis, G. C. M. (2025). A scoping review evaluating the current state of gut microbiota and its metabolites in valvular heart disease physiopathology. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14381

Vancouver

Chong-Nguyen C, Yilmaz B, Coles B, Sokol H, MacPherson A, Siepe M, et al. A scoping review evaluating the current state of gut microbiota and its metabolites in valvular heart disease physiopathology. European Journal of Clinical Investigation. 2025. doi:10.1111/eci.14381

BibTeX
@article{ChongNguyen2025,
  author = {Chong-Nguyen, Caroline and Yilmaz, Bahtiyar and Coles, Bernadette and Sokol, Harry and MacPherson, Andrew and Siepe, Matthias and Reineke, David and Mosbahi, Selim and Tomii, Daijiro and Nakase, Masaaki and Atighetchi, Sarah and Ferro, Cyril and Wingert, Christoph and Gräni, Christoph and Pilgrim, Thomas and Windecker, Stephan and Blasco, Hélène and Dupuy, Camille and Emond, Patrick and Banz, Yara and Losmanovà, Tereza and Döring, Yvonne and Siontis, George C M},
  title = {A scoping review evaluating the current state of gut microbiota and its metabolites in valvular heart disease physiopathology},
  journal = {European Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1111/eci.14381}
}
Kostenlos starten →